A critical juncture: Reimagining a unified, integrated HIV response in South Africa
DOI:
https://doi.org/10.7196/SAMJ.2026.v116i1.4454Keywords:
HIV, health system financing, PEPFARAbstract
-
References
1. Joint United Nations Programme on HIV/AIDS. About the impact of US funding cuts on the global HIV response. Geneva: UNAIDS, 2025. https://www.unaids.org/en/impact-US-funding-cuts/About (accessed 11 March 2025).
2. Chigwedere P, Seage GR, Gruskin S, Lee TH, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr 2008;49(4):410-415. https://doi.org/10.1097/ qai.0b013e31818a6cd5
3. Joint United Nations Programme on HIV/AIDS. AIDS, crisis and the power to transform: UNAIDS Global AIDS Update 2025. Geneva: UNAIDS, 2025. https://www.unaids.org/sites/default/files/2025- 07/2025-global-aids-update-summary_en.pdf (accessed 11 March 2025).
4. Nachega JB, Serwadda D, Abimiku A, Sikazwe I, Abdool Karim Q. PEPFAR at 20 - a game-changing impact on HIV in Africa. N Engl J Med 2023;389(1):1-4. https://doi.org/10.1056/NEJMp2304600
5. Zuma K, Simbayi L, Zungu N, et al. The HIV epidemic in South Africa: Key findings from 2017 National
Population-Based Survey. Int J Environ Res Public Health 2022;19(13):8125. https://doi.org/10.3390/
ijerph19138125
6. Meyer-Rath G, Jamieson L, Mudimu E, Imai-Eaton JW, Johnson LF. The cost of the plunge: The impact and cost of a cessation of PEPFAR-supported services in South Africa. AIDS 2025;39(10):1476-1480. https://doi.org/10.1097/QAD.0000000000004272
7. Venter F. Slow-motion denialism - our leaders are allowing the HIV response to collapse. Daily Maverick, 22 July 2025. https://www.dailymaverick.co.za/article/2025-07-22-slow-motion-denialism- sas-leaders-allowing-hiv-response-to-collapse/ (accessed 1 October 2025).
8. MalanM.ThecaseoftheministerandtheHIVactivists:Areweenteringdenialism2.0?BhekisisaCentre for Health Journalism, 21 May 2025. https://bhekisisa.org/health-news-south-africa/2025-05-21-the- case-of-the-minister-and-the-hiv-activists-are-we-entering-denialism-2-0/ (accessed 1 October 2025).
9. JohnsonT.MinisterMotsoaledi-wearenotAfriForum.Wearethereasonyouhaveahealthsystemto defend. Health-e News, 16 May 2025. https://health-e.org.za/2025/05/16/minister-motsoaledi-we-are- not-afriforum-we-are-the-reason-you-have-a-health-system-to-defend/ (accessed 1 October 2025).
10. Skosana S. Calls for South Africa to build sustainable HIV programmes, reduce reliance on donors. Health-e News, 10 September 2025. https://health-e.org.za/2025/09/10/calls-for-south-africa-to- build-sustainable-hiv-programmes-reduce-reliance-on-donors/ (accessed 1 October 2025).
11. Fatti G, Ngorima-Mabhena N, Tiam A, et al. Community-based differentiated service delivery models incorporating multi-month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits: A pooled analysis of two cluster-randomised trials in southern Africa. J Int AIDS Soc 2021;24(S6):e25819. https://doi.org/10.1002/jia2.25819
12. World Health Organization. Updated recommendations on service delivery for the treatment and care of people living with HIV. Geneva: WHO, 2021. https://www.who.int/publications/i/ item/9789240023581(accessed 1 October 2025)
13. Bekker LG, Das M, Abdool Karim Q, et al. Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women. N Engl J Med 2024;391(13):1179-1192. https://doi.org/10.1056/NEJMoa2407001
Downloads
Published
Issue
Section
License
Copyright (c) 2026 K Rees, G Wolvaardt, T Chidarikire, J J Dietrich, L Ibisomi, T Kufa-Chakezha, T Mabuto, G Maimela, E Mudimu, L Scott, P Smith, N Sohaba, C Chetty-Makkan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.





